Literature DB >> 32015793

The Challenge of High Drug Prices in America: Cost Disclosure in Direct-to-Consumer Advertising May Offer a Solution.

Kamille Garness1.   

Abstract

Year:  2019        PMID： 32015793      PMCID： PMC6979044     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN： 1942-2962


× No keyword cloud information.
  5 in total

Review 1.  Foreign free riders and the high price of US medicines.

Authors:  Donald W Light; Joel Lexchin
Journal:  BMJ       Date:  2005-10-22

2.  Access, affordability, and insurance complexity are often worse in the United States compared to ten other countries.

Authors:  Cathy Schoen; Robin Osborn; David Squires; Michelle M Doty
Journal:  Health Aff (Millwood)       Date:  2013-11-13       Impact factor: 6.301

3.  Getting to the Root of High Prescription Drug Prices.

Authors:  Henry Waxman; Bill Corr; Kristi Martin; Sophia Duong
Journal:  Issue Brief (Commonw Fund)       Date:  2017-07

4.  Strategies used by adults to reduce their prescription drug costs: United States, 2013.

Authors:  Robin A Cohen; Maria A Villarroel
Journal:  NCHS Data Brief       Date:  2015-01

5.  Strategies that delay or prevent the timely availability of affordable generic drugs in the United States.

Authors:  Gregory H Jones; Michael A Carrier; Richard T Silver; Hagop Kantarjian
Journal:  Blood       Date:  2016-01-27       Impact factor: 22.113
  5 in total
  1 in total

1.  Does price disclosure in pharmaceutical advertising result in price transparency? Evidence from a randomized experiment.

Authors:  Ilene L Hollin; Jennifer Gerard Ball
Journal:  Explor Res Clin Soc Pharm       Date:  2022-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.